238 related articles for article (PubMed ID: 29020189)
1. Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.
Walker M; Pion SDS; Fang H; Gardon J; Kamgno J; Basáñez MG; Boussinesq M
Clin Infect Dis; 2017 Nov; 65(12):2026-2034. PubMed ID: 29020189
[TBL] [Abstract][Full Text] [Related]
2. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.
Gardon J; Boussinesq M; Kamgno J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO
Lancet; 2002 Jul; 360(9328):203-10. PubMed ID: 12133654
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
4. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
5. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
6. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT
Trans R Soc Trop Med Hyg; 1999; 93(2):189-94. PubMed ID: 10450448
[TBL] [Abstract][Full Text] [Related]
7. Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses.
Chippaux JP; Boussinesq M; Fobi G; Lafleur C; Audugé A; Banos MT; Ngosso A; Prod'hon J
Ophthalmic Epidemiol; 1999 Dec; 6(4):229-46. PubMed ID: 10544338
[TBL] [Abstract][Full Text] [Related]
8. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
9. Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments.
Bottomley C; Isham V; Collins RC; Basáñez MG
Parasitology; 2008 Nov; 135(13):1571-81. PubMed ID: 18831801
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
[TBL] [Abstract][Full Text] [Related]
11. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
12. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
Alley WS; van Oortmarssen GJ; Boatin BA; Nagelkerke NJ; Plaisier AP; Remme JH; Lazdins J; Borsboom GJ; Habbema JD
BMC Public Health; 2001; 1():12. PubMed ID: 11734070
[TBL] [Abstract][Full Text] [Related]
13. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
14. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
Katabarwa MN; Eyamba A; Nwane P; Enyong P; Yaya S; Baldiagaï J; Madi TK; Yougouda A; Andze GO; Richards FO
Am J Trop Med Hyg; 2011 Dec; 85(6):1041-9. PubMed ID: 22144441
[TBL] [Abstract][Full Text] [Related]
15. River Blindness: Mathematical Models for Control and Elimination.
Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
[TBL] [Abstract][Full Text] [Related]
16. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis.
Basáñez MG; Pion SD; Boakes E; Filipe JA; Churcher TS; Boussinesq M
Lancet Infect Dis; 2008 May; 8(5):310-22. PubMed ID: 18471776
[TBL] [Abstract][Full Text] [Related]
17. River blindness.
Unnasch TR
Lancet; 2002 Jul; 360(9328):182-3. PubMed ID: 12133647
[No Abstract] [Full Text] [Related]
18. Good news on a tropical disease.
Kennedy D
Science; 2002 May; 296(5572):1365. PubMed ID: 12029099
[No Abstract] [Full Text] [Related]
19. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
20. Ten years of NGDO action against river blindness.
Drameh PS; Richards FO; Cross C; Etya'alé DE; Kassalow JS
Trends Parasitol; 2002 Sep; 18(9):378-80. PubMed ID: 12377246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
